About Pompe Disease
Clinical Trial Process
Donations
EP Magazine Article Living with Pompe Disease
Events
Guest Book
Patient Registry
Videos
Related Articles
Contact Us
Home
Contact Us

To find out more about our services and how they may benefit you contact us.

United Pompe Foundation David W. Hamlin
5100 N. Sixth Street #119
Fresno, CA 93710
Phone: (559) 227-1898
Fax: (559) 227-1898
email: david@unitedpompe.com

 



 

   
 
 Upcoming Events/New Items  Links

DUKE UNIVERSITY-UNITED POMPE FOUNDATION POMPE PATIENT MEETING
Pompe Family Meeting
Community Update for Pompe Families in the United States who Utilize Myozyme®
ADVANCE Study Fact Sheet
Amicus Therapeutics Announces First Patient in Phase 2 Study for Pompe Disease
AMICUS POMPE COMMUNITY UPDATE NEWSLETTER
Amicus Therapeutics Announces FDA Agreement to Commence Phase 2 Study of AT2220 Co-administered with Enzyme Replacement Therapy for Pompe Disease
Sanofi-aventis to Acquire Genzyme
BioMarin Initiates Phase 1/2 Trial for BMN 701 for the Treatment of Pompe Disease
POMPE IN COMMON WINTER 2010 EDITION
GENZYME: THE MAKING OF PROTEIN THERAPIES VIDEO
United States Pompe Program Update, August 9, 2010
UNITED STATES POMPE PROGRAM UPDATE, MAY 25, 2010
GENZYME RECEIVES FDA APPROVAL FOR LUMIZYME FOR POMPE DISEASE
US Pompe Program Update – December 3, 2009
POMPE PROGRAM UPDATE MAY 22, 2009
Pompe Program Update March 2, 2009
Genzyme Receives Complete Response Letter from FDA on Lumizyme Application
MYOZYME® (2000 L) SUPPLY UPDATE _US VERSION_JANUARY 2009
GUIDANCE TO THE POMPE COMMUNITY ON THE MANAGEMENT OF MYOZYME SUPPLY
GENZYME POMPE PROGRAM UPDATE NOVEMBER 17, 2008
MYOZYME PRODUCED AT THE 2000L BIOREACTOR SCALE TO RECEIVE ACCELERATED APPROVAL
Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
Genzyme Provides Update on Myozyme® Manufacturing
Genzyme Study of Myozyme® for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease
REHABILITATION MANAGEMENT OF POMPE DISEASE: GREGORY T. CARTER, MD, MS

THE MYOZYME MIRACLE
FDA APPROVES GENZYMES MYOZYME® FOR ALL PATIENTS WITH POMPE DISEASE
Expensive drug gives hope to rare disease sufferer
 

POMPE INCOMMON
New Zealand Pompe Network website
LUMIZYME HOME PAGE
HOME ADAPTIONS: SHARON KRUEGER
Canadian Association of Pompe
"WEAKLING WILLIE" BOOK
FLYING WITH A VENTILATOR IN THE USA
Association for Glycogen Storage Disease
JUAN MAGDARAOG BLOG
Myozyme Home Page
EXPRESSION OF HOPE
Amicus Therapeutics
UK Pompe Group
Helping Hands Loving Hearts
International Pompe Association IPA
Clinical Trial Information
Genzyme's Pompe Website
 
Pompe Disease | Clinical Trial Process | Donations | EP Magazine Article "Living With Pompe Disease"
Events | Guest Book | Patient Registry | Videos | Related Articles | Contact Us | Home
United Pompe 2012 All Rights Reserved.